These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20156376)

  • 1. Feasibility of using guidelines to choose treatment for prostate cancer.
    Mohan R; Beydoun H; Davis J; Lance R; Schellhammer P
    Can J Urol; 2010 Feb; 17(1):4975-84. PubMed ID: 20156376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era.
    Carter CA; Donahue T; Sun L; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Jackmaan S; Moul JW
    J Clin Oncol; 2003 Nov; 21(21):4001-8. PubMed ID: 14581423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' survival expectations before localized prostate cancer treatment by treatment status.
    Mohan R; Beydoun H; Barnes-Ely ML; Lee L; Davis JW; Lance R; Schellhammer P
    J Am Board Fam Med; 2009; 22(3):247-56. PubMed ID: 19429730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
    Adolfsson J; Tribukait B; Levitt S
    Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
    Ladjevardi S; Sandblom G; Berglund A; Varenhorst E
    Eur Urol; 2010 Apr; 57(4):631-8. PubMed ID: 19299069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment on: tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
    Gallina A
    Eur Urol; 2010 Apr; 57(4):639. PubMed ID: 19299073
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: tumor grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
    Yossepowitch O
    Eur Urol; 2010 Apr; 57(4):639-40. PubMed ID: 19299071
    [No Abstract]   [Full Text] [Related]  

  • 8. Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era.
    Shimizu F; Igarashi A; Fukuda T; Kawachi Y; Minowada S; Ohashi Y; Fujime M
    Jpn J Clin Oncol; 2007 Oct; 37(10):763-74. PubMed ID: 17956899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of watchful waiting for clinically localized prostate cancer.
    Steinberg GD; Bales GT; Brendler CB
    J Urol; 1998 May; 159(5):1431-6. PubMed ID: 9554328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
    Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
    J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].
    Soulié M; Villers A; Richaud P; Prapotnich D; Ruffion A; Grosclaude P
    Prog Urol; 2001 Dec; 11(6):1195-204. PubMed ID: 11859652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of clinically localized prostate cancer. Part I--observation or treatment?].
    Szelachowska J; Kornafel J; Gisterek I
    Pol Merkur Lekarski; 2006 Dec; 21(126):594-7. PubMed ID: 17405305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of localized prostate cancer in senior adults: the crucial role of comorbidity.
    Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 2():16-22. PubMed ID: 18307688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
    de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy.
    Zietman AL; Thakral H; Wilson L; Schellhammer P
    J Urol; 2001 Nov; 166(5):1702-6. PubMed ID: 11586206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
    Dahm P; Yeung LL; Chang SS; Cookson MS
    J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical review: is watchful waiting a viable management option for older men with prostate cancer?
    Bailey DE; Wallace M
    Am J Mens Health; 2007 Mar; 1(1):18-28. PubMed ID: 19482780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best practice statement on cryosurgery for the treatment of localized prostate cancer.
    Babaian RJ; Donnelly B; Bahn D; Baust JG; Dineen M; Ellis D; Katz A; Pisters L; Rukstalis D; Shinohara K; Thrasher JB
    J Urol; 2008 Nov; 180(5):1993-2004. PubMed ID: 18817934
    [No Abstract]   [Full Text] [Related]  

  • 20. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
    Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
    J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.